Patent · US Active

IL-22 Fc fusion proteins

US9815880B2 · kind B2 · utility

11Cited by
49References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 22, 2016
Grant dateNov 14, 2017
Priority date
Expiry dateJul 22, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to IL-22 polypeptides, IL-22 Fc fusion proteins and IL-22 agonists, composition comprising the same, methods of making and methods of using the composition for the treatment of diseases. The invention also relates to IL-22 receptor associated reagents and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.